EW Healthcare Partners Closes $745 Million Fund to Invest in Pharma and MedTech Companies

On August 26, 2019, VCBeat (WeChat ID: vcbeat) learned that healthcare investment firm EW Healthcare Partners had closed a $745 million fundraising round through its second dedicated growth equity fund, EW Healthcare Partners Fund 2a (“Fund 2a”). Other details of the transaction were not disclosed.

EW Healthcare Partners has raised over $650 million in this financing round and plans to use the proceeds to invest in healthcare companies in the pharmaceutical and medical device sectors that are experiencing rapid growth and have achieved successful commercialization.

Petri Vainio, Managing Director and Chairman of the Executive Committee at EW Healthcare Partners, stated, “We primarily create value for investors as well as for the shareholders and management teams of our portfolio companies. The capital from Fund IIa will be deployed to help emerging healthcare companies enhance their profitability. We mainly invest in mid-market companies with revenues between $20 million and $200 million that are poised to achieve annual revenue growth of approximately 20% in the coming years. We believe that, leveraging our expertise in the healthcare sector along with our experienced operational partners and senior advisory team, we will attract more pharmaceutical and medical device companies.”

Marty Sutter, Co-Founder and Chairman of the Investment Committee at EW Healthcare Partners, stated, “Our mission is to be hands-on, forward-thinking, collaborative, and value-driven. Our Fund I successfully invested in several promising healthcare companies, and we look forward to building a successful portfolio of healthcare companies in Fund IIa. Our goal is to provide capital that drives revenue growth by expanding sales forces, broadening business scope, acquiring complementary products or companies, and developing and launching new products.”

EW Healthcare Partners, founded in 1985, is one of the world’s oldest and most respected healthcare investment firms. The firm is dedicated to making growth equity investments in rapidly commercializing healthcare companies across the pharmaceutical, medical device, diagnostics, and technology sectors. Since its inception, EW Healthcare Partners has raised nearly $4 billion and has become a long-term investor in more than 150 healthcare companies spanning diverse industries, stages, and geographies. The EW Healthcare Partners team comprises 23 investment professionals with deep industry expertise, most of whom are senior executives and operators from leading global healthcare companies, as well as distinguished physicians and scientists. The firm maintains offices in Palo Alto, Houston, New York, and London.

(Compiled by Tian Shuhang)